Unknown

Dataset Information

0

Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patients.


ABSTRACT: BACKGROUND:Routine work-up for transarterial radioembolization, based on clinical and laboratory parameters, sometimes fails, resulting in severe hepatotoxicity in up to 5% of patients. Quantitative assessment of the pretreatment liver function and its segmental distribution, using hepatobiliary scintigraphy may improve patient selection and treatment planning. A case series will be presented to illustrate the potential of this technique. Hepatocellular carcinoma patients with cirrhosis (Child-Pugh A and B) underwent hepatobiliary scintigraphy pre- and 3 months post-radioembolization as part of a prospective study protocol, which was prematurely terminated because of limited accrual. Included patients were analysed together with their clinical, laboratory and treatment data. RESULTS:Pretreatment-corrected 99mTc-mebrofenin liver uptake rates were marginal (1.8-3.0%/min/m2), despite acceptable clinical and laboratory parameters. Posttreatment liver functions seriously declined (corrected 99mTc-mebrofenin liver uptake rates: 0.6-2.4%/min/m2), resulting in lethal radioembolization-induced liver disease in two out of three patients. CONCLUSIONS:Hepatobiliary scintigraphy may be of added value during work-up for radioembolization, to estimate liver function reserve and its segmental distribution, especially in patients with underlying cirrhosis, for whom analysis of clinical and laboratory parameters may not be sufficient.

SUBMITTER: Braat MNGJA 

PROVIDER: S-EPMC5215993 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patients.

Braat Manon N G J A MNGJA   de Jong Hugo W HW   Seinstra Beatrijs A BA   Scholten Mike V MV   van den Bosch Maurice A A J MAAJ   Lam Marnix G E H MGEH  

EJNMMI research 20170105 1


<h4>Background</h4>Routine work-up for transarterial radioembolization, based on clinical and laboratory parameters, sometimes fails, resulting in severe hepatotoxicity in up to 5% of patients. Quantitative assessment of the pretreatment liver function and its segmental distribution, using hepatobiliary scintigraphy may improve patient selection and treatment planning. A case series will be presented to illustrate the potential of this technique. Hepatocellular carcinoma patients with cirrhosis  ...[more]

Similar Datasets

| S-EPMC6785787 | biostudies-literature
| S-EPMC8596669 | biostudies-literature
| S-EPMC8172845 | biostudies-literature
| S-EPMC6194760 | biostudies-literature
| S-EPMC7005767 | biostudies-literature
| S-EPMC10006243 | biostudies-literature
| S-EPMC10684706 | biostudies-literature
| S-EPMC6541348 | biostudies-literature
| S-EPMC6682576 | biostudies-literature
| S-EPMC8437291 | biostudies-literature